JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy. 2014

Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
1] Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China [2] Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China 310016 [3].

Deficiency or mutation in the p53 tumor suppressor gene commonly occurs in human cancer and can contribute to disease progression and chemotherapy resistance. Currently, although the pro-survival or pro-death effect of autophagy remains a controversial issue, increasing data seem to support the idea that autophagy facilitates cancer cell resistance to chemotherapy treatment. Here we report that 5-FU treatment causes aberrant autophagosome accumulation in HCT116 p53(-/-) and HT-29 cancer cells. Specific inhibition of autophagy by 3-MA, CQ or small interfering RNA treatment targeting Atg5 or Beclin 1 can potentiate the re-sensitization of these resistant cancer cells to 5-FU. In further analysis, we show that JNK activation and phosphorylation of Bcl-2 are key determinants in 5-FU-induced autophagy. Inhibition of JNK by the compound SP600125 or JNK siRNA suppressed autophagy and phosphorylation of c-Jun and Bcl-2 but increased 5-FU-induced apoptosis in both HCT116 p53(-/-) and HT29 cells. Taken together, our results suggest that JNK activation confers 5-FU resistance in HCT116 p53(-/-) and HT29 cells by promoting autophagy as a pro-survival effect, likely via inducing Bcl-2 phosphorylation. These results provide a promising strategy to improve the efficacy of 5-FU-based chemotherapy for colorectal cancer patients harboring a p53 gene mutation.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008869 Microtubule-Associated Proteins High molecular weight proteins found in the MICROTUBULES of the cytoskeletal system. Under certain conditions they are required for TUBULIN assembly into the microtubules and stabilize the assembled microtubules. Ensconsin,Epithelial MAP, 115 kDa,Epithelial Microtubule-Associate Protein, 115 kDa,MAP4,Microtubule Associated Protein,Microtubule Associated Protein 4,Microtubule Associated Protein 7,Microtubule-Associated Protein,Microtubule-Associated Protein 7,E-MAP-115,MAP1 Microtubule-Associated Protein,MAP2 Microtubule-Associated Protein,MAP3 Microtubule-Associated Protein,Microtubule Associated Proteins,Microtubule-Associated Protein 1,Microtubule-Associated Protein 2,Microtubule-Associated Protein 3,7, Microtubule-Associated Protein,Associated Protein, Microtubule,E MAP 115,Epithelial Microtubule Associate Protein, 115 kDa,MAP1 Microtubule Associated Protein,MAP2 Microtubule Associated Protein,MAP3 Microtubule Associated Protein,Microtubule Associated Protein 1,Microtubule Associated Protein 2,Microtubule Associated Protein 3,Microtubule-Associated Protein, MAP1,Microtubule-Associated Protein, MAP2,Microtubule-Associated Protein, MAP3,Protein 7, Microtubule-Associated,Protein, Microtubule Associated,Protein, Microtubule-Associated
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071186 Beclin-1 An autophagy related protein which functions as a core subunit of PHOSPHATIDYLINOSITOL 3-KINASE MULTIPROTEIN COMPLEXES. It mediates the formation of phosphatidylinositol 3-phosphate and functions in AUTOPHAGY, where it is required for maturation of the AUTOPHAGOSOME. It also functions in ENDOCYTOSIS and CYTOKINESIS as part of a separate complex. Beclin-1 associates with INTRACELLULAR MEMBRANES and interacts with the PROTO-ONCOGENE PROTEINS C-BCL-2 and BCL-X PROTEIN. ATG-6 Protein,ATG6 Protein,Beclin-1 Protein,Beclin1,Coiled-coil Myosin-like Bcl2-interacting Protein,GT197 Protein,ATG 6 Protein,Beclin 1,Beclin 1 Protein,Coiled coil Myosin like Bcl2 interacting Protein
D000071187 Autophagy-Related Protein 5 An autophagy-related protein that functions in AUTOPHAGOSOME biogenesis. It is conjugated to the ATG12 PROTEIN via a process that is similar to UBIQUITINATION and involves the ATG7 PROTEIN and ATG10 enzyme. The ATG12-ATG5 conjugate acts as an E3 UBIQUITIN LIGASE-like enzyme and is required for the localization of ATG8 PROTEINS to AUTOPHAGOSOME vesicle membranes and modification of membrane lipids. ATG-5 Protein,ATG5 Protein,Apoptosis-Specific Protein,Autophagy Protein-5,Autophagy-Related 5 Protein,ATG 5 Protein,Apoptosis Specific Protein,Autophagy Protein 5,Autophagy Related 5 Protein,Autophagy Related Protein 5
D000873 Anthracenes A group of compounds with three aromatic rings joined in linear arrangement.

Related Publications

Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
November 2017, Experimental cell research,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
November 2009, Cancer biology & therapy,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
July 2012, Autophagy,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
May 2017, Biomolecules & therapeutics,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
June 2007, Journal of experimental & clinical cancer research : CR,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
January 2013, Oncology letters,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
August 2017, Scientific reports,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
January 2014, PloS one,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
February 2017, Biochimica et biophysica acta. Molecular cell research,
Xinbing Sui, and Na Kong, and Xian Wang, and Yong Fang, and Xiaotong Hu, and Yinghua Xu, and Wei Chen, and Kaifeng Wang, and Da Li, and Wei Jin, and Fang Lou, and Yu Zheng, and Hong Hu, and Liu Gong, and Xiaoyun Zhou, and Hongming Pan, and Weidong Han
June 2014, Carcinogenesis,
Copied contents to your clipboard!